![](/images/graphics-bg.png)
A Case of Sclerosing Mesenteritis during Etanercept Therapy for Psoriatic Arthritis
Author
Source
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-07-13
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Sclerosing mesenteritis (SM) is a chronic nonspecific mesenteric inflammation.
I report a case of a 72-year-old male treated with etanercept for psoriatic arthritis for 7 years who developed abdominal discomfort, urinary retention, acute kidney injury, and bilateral ureteric obstruction.
CT abdomen revealed retroperitoneal mass.
Biopsy showed sclerosing mesenteritis.
One year later, after discontinuation of etanercept, CT abdomen showed regression of the mass.
To my knowledge, this is first case report of reversible sclerosing mesenteritis associated with etanercept therapy.
American Psychological Association (APA)
Bukiej, Aleksandra. 2020. A Case of Sclerosing Mesenteritis during Etanercept Therapy for Psoriatic Arthritis. Case Reports in Rheumatology،Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1151255
Modern Language Association (MLA)
Bukiej, Aleksandra. A Case of Sclerosing Mesenteritis during Etanercept Therapy for Psoriatic Arthritis. Case Reports in Rheumatology No. 2020 (2020), pp.1-3.
https://search.emarefa.net/detail/BIM-1151255
American Medical Association (AMA)
Bukiej, Aleksandra. A Case of Sclerosing Mesenteritis during Etanercept Therapy for Psoriatic Arthritis. Case Reports in Rheumatology. 2020. Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1151255
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1151255